[Edaily Reporter JAEMIN SONG ] “The prismatic LFP production line for energy storage systems (ESS) in the U.S. is currently in the mass production quality verification phase. As originally planned, we will begin mass production of cells this October and plan to start supplying customers with the SBB 2.0 solution by the end of the year. For LFP cathode material—the cornerstone of our non-PFE supply chain—we have already secured the necessary volume through various partnerships centered on domestic and U.S. companies. We have also established a supply chain that meets non-Chinese origin standards by promoting localization of other key components with our partners.”
(Photo: Blind)
One of the concerns facing the Lee Jae-myung administration is the decline in support among young people. According to Gallup Korea’s presidential job approval ratings, the approval…
The KRX Health Care Index rose 4.53% from the previous session on Oct. 1, signaling a rare tailwind for South Korea’s pharmaceutical and biotech sector. Among the gainers, GIInnovation and G2GBio drew…
(Graphic: ChatGPT)
“While existing ex vivo chimeric antigen receptor T-cell (CAR-T) therapies are personalized treatments that require cell collection from each patient for manufacturing, the in v…
